Zydus Life Shares Gain 2% as Arm inks Agreement With Synthon BV
September 5, 2025September 5, 2025 Shares of Zydus Lifesciences Ltd were trading 2% higher on 5 September after the company announced that its wholly-owned subsidiary, Zydus Lifesciences Global FZE, signed an exclusive licensing and supply deal with Synthon BV of the Netherlands for Ozanimod Capsules for the US market….